These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38928103)

  • 21. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
    DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
    J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
    Paquette JS; Fortin JF; Blanchard L; Tremblay MJ
    J Virol; 1998 Nov; 72(11):9329-36. PubMed ID: 9765484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.
    Sorin M; Cano J; Das S; Mathew S; Wu X; Davies KP; Shi X; Cheng SW; Ott D; Kalpana GV
    PLoS Pathog; 2009 Jun; 5(6):e1000463. PubMed ID: 19503603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent Protein Inserts in between NC and SP2 are Tolerated for Assembly, Release and Maturation of HIV with Limited Infectivity.
    Bendjennat M; Saffarian S
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31652757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice.
    Kleinpeter AB; Zhu Y; Mallery DL; Ablan SD; Chen L; Hardenbrook N; Saiardi A; James LC; Zhang P; Freed EO
    J Mol Biol; 2023 Jun; 435(11):168037. PubMed ID: 37330292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.
    Murakami T; Carmona N; Ono A
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8055-8063. PubMed ID: 32193343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
    Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Virion Analysis: A Method to Visualize HIV-1 Particle Content Using Fluorescence Microscopy.
    Duchon A; Burdick RC; Pathak VK; Hu WS
    Methods Mol Biol; 2024; 2807():77-91. PubMed ID: 38743222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1.
    Pan Q; Rong L; Zhao X; Liang C
    Virology; 2009 Apr; 387(1):127-35. PubMed ID: 19249802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
    Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virion-Packaged Pyruvate Kinase Muscle Type 2 Affects Reverse Transcription Efficiency of Human Immunodeficiency Virus Type 1 by Blocking Virion Recruitment of tRNA
    Mouree KR; Kishimoto N; Iga N; Kirihara C; Yamamoto K; Takamune N; Misumi S
    Biol Pharm Bull; 2018; 41(4):612-618. PubMed ID: 29607934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
    Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
    J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.
    Bogerd HP; Kennedy EM; Whisnant AW; Cullen BR
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.
    Staudt RP; Smithgall TE
    J Biol Chem; 2020 Nov; 295(46):15540-15552. PubMed ID: 32873704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
    Rossio JL; Esser MT; Suryanarayana K; Schneider DK; Bess JW; Vasquez GM; Wiltrout TA; Chertova E; Grimes MK; Sattentau Q; Arthur LO; Henderson LE; Lifson JD
    J Virol; 1998 Oct; 72(10):7992-8001. PubMed ID: 9733838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.